• Most Popular
  • Most Shared

Vectura erectile dysfunction drug test successful

Mon Apr 23, 2007 2:27am EDT

Stocks

   

LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc (VEC.L) said on Monday a phase two clinical study on its inhaled erectile dysfunction product had been successful.

Vectura said in the second double-blind placebo-controlled trial VR004 improved erectile performance, with a rapid onset of action, and was well tolerated.

((Reporting by Jonathan Cable

Editing by Erica Billingham

Reuters messaging: rm://jonathan.cable.reuters.com@reuters.net

Telephone +44 20 7542 4688

Email jonathan.cable@reuters.com)) Keywords: VECTURA TRIAL/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWLB7957GB/SMALL


More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The Obama administration said on Sunday it was investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet and sought to head off Republican attacks over its anti-terrorism measures. | Video

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets